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Alzheimer’s disease (AD) is widely considered to be caused by amyloid-b peptide (Ab) accumulation
in the brain. Ab is excised from amyloid-b precursor protein through sequential cleavage by b-secre-
tase 1 (BACE1) and c-secretase. Thus, BACE1 inhibition could prevent Ab accumulation. Here, we
identiﬁed myo-inositol hexakisphosphate (IP6) as a BACE1 inhibitory molecule in rice grain extract
and digest. The rice digest and IP6 signiﬁcantly inhibited Ab production in neuroblastoma cells with-
out cytotoxicity. These results suggested that rice components, including IP6, may be promising
starting materials for the development of potent and safe drugs and/or food to prevent AD.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).1. Introduction
Alzheimer’s disease (AD) is the most prevalent cause of senile
dementia. Accumulation of amyloid-b peptide (Ab) in the brain is
widely considered to be critically involved in the pathogenesis of
AD [1]. Ab plaques emerge roughly 15 years before the symptoms
of AD appear [2]. Once AD develops, cognitive decline that is
caused by neuronal damage cannot be reversed, even after Ab lev-
els in the brain are lowered by immunotherapy [3]. Thus, the pre-
vention of Ab accumulation is important to prevent AD. Ab is
excised from amyloid-b precursor protein (APP) through sequen-
tial cleavage by aspartic protease b-secretase 1 (BACE1) and c-
secretase [1,4]. Because BACE1 initiates the processing of Ab, inhi-
bition of BACE1 activity could be an effective measure to prevent
Ab accumulation [5].
Many epidemiologic surveys have indicated that lifestyle,
including diet habits, affect the incidence rate of AD [6–8]. Cohort
studies have shown that when a group of Japanese citizens immi-grated to Hawaii and then to the US mainland, their AD rate grad-
ually increased from the Asian level to the Western level [9]. With
respect to diet, the staple food in Western countries is wheat,
whereas in Japan, it is rice. Thus, we hypothesized that rice grains
might contain some components that prevent Ab accumulation in
the brain.
Here, we showed that rice extracts and digest indeed inhibit
BACE1 activity in vitro and that the rice digest inhibited Ab produc-
tion in cultured human neuroblastoma cells. We further identiﬁed
phytic acid (also called IP6, myo-inositol hexakisphosphate) as one
of the potent components by ion chromatography. We demon-
strated that IP6 inhibited BACE1 activity in vitro and Ab production
in cultured human neuroblastoma cells.2. Materials and methods
2.1. Reagents
Rice-derived phytic acid sodium salt [IP6 (SS), C6H18O24P6-
xNa + yH2O], phytic acid dipotassium salt [IP6 (PS), MR: 736.22],
D-myo-inositol 1,4,5,6-tetrakisphosphate potassium salt (IP4),
and D-myo-inositol 1,4,5-tris–phosphate trisodium salt (IP3) were
purchased from Sigma–Aldrich Co. LLC (St. Louis, MO). D-myo-ino-
sitol 1,3,4,5,6-pentakisphosphate pentapotassium salt (IP5) was
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
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Unpolished or polished rice grains or bread ﬂour was extracted
in 10 volumes (w/v) of the BACE1 assay buffer (see below) for 1 h
at room temperature. Undissolved components were removed by
centrifugation at 11,000g for 20 min at 4 C. The supernatant
was heated at 95 C for 30 min to inactivate the rice or ﬂour-de-
rived proteases and then centrifuged at 11,000g for 10 min at
4 C. The supernatant was then subjected to a BACE1 activity assay.
For the in vitro digestion, unpolished rice grains were incubated
in 10 volumes (w/v) of 0.26% pepsin (Sigma–Aldrich Co. LLC) in
ultrapure water–HCl (pH 2.0) for 2.5 h at 37 C. The pH of the pep-
sin digest was raised to 5.5 by dropwise addition of 1 M NaHCO3.
After addition of pancreatin (Sigma–Aldrich Co. LLC) at a ﬁnal con-
centration of 0.7%, the digest was further incubated for 2 h at 37 C,
and then heated at 100 C for 20 min to inactivate the enzymes.
The digest was centrifuged at 12,000g for 20 min at 4 C, and
the supernatant was collected and separated using a 5K MWCO
spin ﬁlter (catalog No. UFC900524, Merck KGaA, Darmstadt, Ger-
many). The ﬂow-through fraction (termed 5k-lower) was collected
and subjected to a BACE1 activity assay, a cell-based Ab production
activity assay, and a cytotoxicity assay.
2.3. In vitro BACE1 activity assay
BACE1 activity was determined using recombinant human
BACE1 (Sigma–Aldrich Co., LLC) and a ﬂuorogenic H-
RE(EDANS)EVNLDAEFK(DABCYL)R-OH substrate (catalog No.
565758, Merck KGaA). The assays were performed in the BACE1 as-
say buffer [20 mM acetate buffer (pH 4.5)/0.1% Triton X-100/0.05%
CHAPS] in black 96-well microplates (PerkinElmer Inc., Waltham,
MA). Each well contained 10 lM of the substrate, 0.2 lg/ml of
BACE1 and the test samples or b-secretase inhibitor III (catalog
No. 565780, Merck KGaA) in a ﬁnal volume of 60 ll. The mixture
was incubated for 5 h at 37 C or for 17 h at 25 C, and the substrate
cleavage was determined by measuring ﬂuorescence (excitation at
355 nm, emission at 490 nm) using a Wallac 1420 plate reader
(PerkinElmer Inc.). The data that were obtained were assessed for
statistical signiﬁcance using the Student’s t-test.
2.4. Cell-based Ab production activity and cytotoxicity assays
SH-SY5Y human neuroblastoma cells were cultured in Dul-
becco’s Modiﬁed Eagle Medium: Nutrient Mixture F-12 medium
supplemented with 10% fetal bovine serum at 37 C in a 5% CO2
atmosphere. The cells were seeded in a 96-well ViewPlate (catalog
No. 6005182, PerkinElmer Inc.) at a density of 8  105 cells/ml with
150 ll of the culture medium in each well and then incubated for
2 h. After removing 15 ll of the culture medium, the cells were
treated with 15 ll of the test samples [rice digest or IP6 (SS) dis-
solved in phosphate-buffered saline (PBS)] for 24 h. Ab1x that
was secreted into the medium was detected by an enzyme-linked
immunosorbent assay (ELISA) according to the method of Yama-
kawa et al. [10] with slight modiﬁcations. In brief, the conditioned
medium (100 ll) was transferred to a Maxisorp plate (catalog No.
436110, Thermo Fisher Scientiﬁc Inc., Waltham, MA) coated with
an 82E1 antibody speciﬁc to the N-terminal end of Ab (Immuno-
Biological Laboratories Co., Ltd., Gunma, Japan). Ab that was cap-
tured on the plate was detected using a biotinylated 4G8 antibody
(Covance Inc., Princeton, NJ), horseradish peroxidase (HRP)-conju-
gated streptavidin (Thermo Fisher Scientiﬁc Inc.), and SuperSignal
ELISA Pico chemiluminescent substrate (Thermo Fisher Scientiﬁc
Inc.). The luminescent signals were measured using the plate
reader.
To check the cytotoxicity of the test samples, MultiTox-Fluor
Multiplex reagent (Promega Corporation, Madison, WI) was addedto the cells in the culture medium (50 ll) that remained in the
ViewPlate. After incubation for 30 min, the signals of the live-cell
marker glycyl-phenylalanyl-amino-ﬂuorocoumarin (GF-AFC)
(excitation at 400 nm, emission at 505 nm) and the dead-cell mar-
ker bis-alanyl-alanyl-phenylalanyl-rhodamine-110 (bis-AAF-R110)
(excitation at 485 nm, emission at 520 nm) were sequentially mea-
sured using the plate reader.
Ab production (shown in Figs. 2A and 6A, and Supplementary
Fig. 1) was expressed as the SuperSignal ELISA Pico chemilumines-
cent count/GF-AFC count.
2.5. Analyses of IP3, IP4, IP5, and IP6 in the rice extract and digest by
ion chromatography
Ion chromatography was performed by Japan Food Research
Laboratories (Tokyo, Japan). In brief, the unpolished rice extract
or digest, or bread ﬂour extract was mixed with trichloroacetic acid
according to the method of Matsunaga et al. [11]. The mixture was
ﬁltered and passed through a Na+-type cation exchange column
(OnGuard II Na 1-cc cartridge, Thermo Fisher Scientiﬁc Inc.). Then,
the ﬂow-through was fractionated using a Dionex ICS-2000 ion
chromatography system with an IonPac AS11 column (Thermo
Fisher Scientiﬁc Inc.) and an electric conductivity detector.
2.6. Western blotting
Cells treated with or without IP6 (SS) for 24 h were harvested
with a cell scraper and lysed with SDS-sample buffer [62.5 mM
Tris–HCl (pH 6.8)/2.3% SDS/10% glycerol]. Protein concentration
of the cell lysate was determined using a BCA protein assay kit
(Thermo Fisher Scientiﬁc Inc.). The proteins were denatured by
boiling for 3 min with 5% b-mercaptoethanol, separated by SDS–
PAGE on an 8–16% polyacrylamide gradient gel, and then blotted
onto a nitrocellulose membrane. The blot was blocked with 5%
non-fat powdered milk in TBST [20 mM Tris–HCl (pH7.6)/
150 mM NaCl/0.1% Tween 20], and then incubated with the follow-
ing antibodies: for the C-terminal fragment of b-cleaved APP (b-
CTF), monoclonal 82E1 antibody; for APP full length protein, mono-
clonal APP(N) (10D1) antibody (Immuno-Biological Laboratories
Co., Ltd.); for BACE1, anti-BACE1 N-terminus (46–62) antibody
(Sigma–Aldrich Co. LLC); for b-actin as an internal control, poly-
clonal beta Actin antibody (GeneTex, Inc., Irvine, CA). The antibod-
ies were then detected with HRP-conjugated protein A/G and
enhanced chemiluminescence (Thermo Fisher Scientiﬁc Inc.).3. Results
3.1. Rice extracts and digest inhibited BACE1 activity
We ﬁrst investigated whether the rice grain components had
BACE1 inhibitory activity by an in vitro BACE1 activity assay. Pol-
ished and unpolished rice extracts markedly inhibited BACE1 activ-
ity compared to the control, which contained only recombinant
BACE1 and the ﬂuorogenic substrate in the assay buffer (Fig. 1).
Unpolished rice was more potent than polished rice, and its po-
tency was comparable to that of 1 lM of b-secretase inhibitor III,
which is a BACE1 substrate analog. Bread ﬂour extract did not exert
signiﬁcant BACE1 inhibitory activity.
We next digested the unpolished rice grains with pepsin and
pancreatin in vitro to mimic the gastrointestinal digestion that oc-
curs in the body. The fraction containing components smaller than
5 kDa of the digest (5k-lower) exhibited a potency that was similar
to that of the unpolished rice extract (Fig. 1). The mixture of pepsin
and pancreatin without rice grains, which was incubated in a sim-
ilar way as the rice digest and then passed through a 5K MWCO
Fig. 1. Comparison of the b-secretase 1 (BACE1) inhibitory activities of ﬂour, rice,
and rice digest. Five microliters of extracts from bread ﬂour, polished rice, and
unpolished rice were subjected to an in vitro BACE1 activity assay, as described in
Section 2. Five microliters of the fractions that contained components smaller than
5 kDa (5k-lower) of the mixture of pepsin and pancreatin (pep + pan) and
unpolished rice digest with pepsin and pancreatin (rice digest) were also assayed.
The control samples contained BACE1 and the ﬂuorogenic substrate in the BACE1
assay buffer without the rice or ﬂour extract. Beta-secretase inhibitor III (inhibitor
III) served as a positive control. Note that the unpolished rice extract and digest
exhibited the highest inhibition among the tested samples. The data are repre-
sented as mean ± standard error of the mean (SEM; n = 3–4). ⁄P < 0.001.
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Fig. 1]. This result excluded the possibility that the observed BACE1
inhibitory activity in the rice digest (5k-lower) sample did not de-
rive from the small components (molecular mass <5 kDa) in the
pepsin or the pancreatin preparation that was used.Fig. 2. Reduction of amyloid-b peptide (Ab) production by the unpolished rice digest in cu
than 5 kDa (5k-lower) of the mixture of pepsin and pancreatin (pep + pan) or unpolishe
described in Section 2. (A) Ab1x that was secreted into the medium was detected by en
using a MultiTox-Fluor Multiplex reagent kit with the (B) live-cell marker glycyl-phen
alanyl-phenylalanyl-rhodamine-110 (bis-AAF-R110). The data (mean ± SEM, n = 3) are e3.2. The rice digest inhibited Ab production in cultured human
neuroblastoma cells
To examine whether the rice components actually inhibit Ab
production in cells, we treated human neuroblastoma (SH-SY5Y)
cells with the 5k-lower fraction of the unpolished rice digest. As
shown in Fig. 2A, the rice digest signiﬁcantly inhibited the Ab pro-
duction compared to that of the control [pepsin and pancreatin
(pep + pan/5k-lower)]. When the rice digest was applied to the
cells, the live cell marker GF-AFC signals tended to increase and
the dead cell marker bis-AAF-R110 signals tended to decrease
(Fig. 2B and C). These results indicated that the rice digest was
not toxic to the cells. Rather, it tended to enhance cell survival.
Decrease of Ab production by the rice digest was also observed
in the cells overexpressing wild-type human APP (APPwt) as
shown in Supplementary Fig. 1A.
3.3. Identiﬁcation of IP6 as a BACE1 inhibitory molecule in the
unpolished rice extract and digest
IP6 is abundant in water-soluble rice bran [12]. Thus, we ana-
lyzed whether IP6 and its degradation products, IP3, IP4, and IP5,
existed in the unpolished rice extract and digest. As shown in
Fig. 3, both the rice extract and digest contained IP6 and IP4, but
IP3 or IP5 were not detected in these samples. We next tested
whether IP3–6 inhibited BACE1 activity by an in vitro BACE1 activ-
ity assay. As shown in Fig. 4, IP6 (SS) strongly inhibited BACE1
activity at a ﬁnal concentration of 1 lg/ml, and this potency was
comparable to that of 1 lM of b-secretase inhibitor III. However,
IP3–5 did not inhibit BACE1 activity at a ﬁnal concentration of
1 lg/ml.
To determine the IC50 value of IP6, we performed an in vitro
BACE1 activity assay using various concentrations of IP6 (PS). IP6
(PS) inhibited BACE1 in a dose-dependent manner, as shown in
Fig. 5, and the IC50 value was estimated to be approximately
0.18 lg/ml (0.25 lM).
We also analyzed IP6 content in the bread ﬂour extract by ion
chromatography. IP6 was undetectable, consistent with the ﬁnding
that the bread ﬂour extract did not inhibit BACE1 activity (see
Fig. 1).ltured SH-SY5Y cells. The cells were treated with the components that were smaller
d rice digest that was treated with pepsin and pancreatin (rice digest) for 24 h, as
zyme-linked immunosorbent assay. The cytotoxicity of the rice digest was assessed
ylalanyl-amino-ﬂuorocoumarin (GF-AFC) and (C) the dead-cell marker bis-alanyl-
xpressed as percentages of the pep + pan treatment. ⁄P = 0.001.
Fig. 3. Identiﬁcation of myo-inositol hexakisphosphate (IP6) and myo-inositol tetrakisphosphate (IP4) in the unpolished rice extract and digest. (A) A chromatogram of the
standard solution containing IP3, IP4, IP5, and IP6 [dipotassium salt (PS)] that was obtained by ion chromatography. The value at each peak represents the retention time (in
minutes) for each component. (B) A chromatogram of the unpolished rice extract. (C) A chromatogram of the unpolished rice digest. (D) Amounts of IP3, IP4, IP5, and IP6 in the
unpolished rice extract and digest that were determined using the standard solution. ND, not detected.
Fig. 4. IP6 [sodium salt (SS)] inhibits BACE1 activity. IP6 (SS), IP5, IP4, and IP3 were
subjected to an in vitro BACE1 activity assay. The control represents a sample
containing only BACE1 and the ﬂuorogenic substrate in the BACE1 assay buffer.
Beta-secretase inhibitor III (inhibitor III) served as a positive control. Note that IP6
(SS) signiﬁcantly inhibited BACE1 activity at 1 lg/ml, while IP3–5 did not show
signiﬁcant inhibition at the same concentration. The data are represented as
mean ± SEM (n = 3). ⁄P < 0.001.
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neuroblastoma cells
We investigated the effects of IP6 on production of Ab and b-CTF
in cultured SH-SY5Y cells. IP6 (SS) signiﬁcantly reduced the Ab
amounts in the culture media in a dose-dependent manner at
10–1000 lg/ml (Fig. 6A). The treatment of the cells with IP6 (SS)
increased the live cell marker GF-AFC signals and decreased the
dead cell marker bis-AAF-R110 signals compared to that of the
control (data not shown), suggesting that IP6 (SS) was not toxic
to the cells. These results were consistent with those of the rice di-
gest shown in Fig. 2. Decrease of Ab production by IP6 (SS) was also
observed in the cells overexpressing human APPwt as illustrated in
Supplementary Fig. 1B.
Treatment with IP6 (SS) also reduced the amount of b-CTF in the
cultured native SH-SY5Y cells (Fig. 6B), consistent with the reduc-
tion of Ab induced by IP6 (SS) treatment. The expression levels of
neither APP nor BACE1 changed by IP6 (SS) treatment (Fig. 6B).
4. Discussion
In this study, we demonstrated that rice grains contained com-
ponents that inhibited BACE1 activity in vitro, as well as Ab produc-
tion in cultured cells (Figs. 1 and 2). Furthermore, we identiﬁed IP6
Fig. 5. Dose-dependent inhibition of BACE1 activity by IP6 (PS). BACE1 activity was determined in the presence of various concentrations of IP6 (PS). The half-maximal
inhibitory concentration (IC50) was 0.18 lg/ml (0.25 lM). The data are represented as mean ± SEM (n = 3).
Fig. 6. Reduced production of Ab and C-terminal fragment of b-cleaved APP (b-CTF) by IP6 (SS) in cultured SH-SY5Y cells. (A) The cells were treated with IP6 (SS) (0–1,000 lg/
ml) dissolved in phosphate-buffered saline (PBS) for 24 h. Note that Ab1x secreted into the culture medium signiﬁcantly decreased in an IP6 dose-dependent manner. The
data (mean ± SEM, n = 3) are expressed as percentages of the sample without IP6 (0 lg/ml). ⁄P < 0.05, ⁄⁄P < 0.001. (B) The cells were treated with PBS (control) or IP6 (SS)
(1,000 lg/ml) for 24 h, harvested, and lysed with SDS-sample buffer. Samples (40 lg protein/lane) were fractionated by SDS–polyacrylamide gel electrophoresis, and then
subjected to immunoblotting (see Section 2 for details). Note that IP6 treatment decreased b-CTF but not APP or BACE1.
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knowledge, this is the ﬁrst report of BACE1 inhibition by rice com-
ponents and IP6. Existing c-secretase inhibitors are known to pro-
duce undesirable side effects in clinical trials due to their low
speciﬁcity toward the APP processing pathway [13,14]. In addition,
the BACE1 inhibitor LY2811376 has been shown to cause adverse
effects in preclinical animal models, although it reduces Ab in the
lumbar cerebrospinal ﬂuid of healthy volunteers [15]. In contrast,
the safety of rice-derived components to the human body has been
warranted by the long history of rice as a staple food in many coun-
tries. Indeed, our ﬁndings indicated that the rice digest was not
toxic to SH-SY5Y cells (Fig. 2). BACE1 inhibitory activity of rice
components remained even after treatment with pepsin and pan-
creatin (Figs. 1 and 2). This suggested that potent activity of the
rice components remains active after gastrointestinal digestion in
the body. Thus, rice components are promising starting materials
for designing drugs to prevent AD by their oral administration.
We identiﬁed IP6 in the unpolished rice extract and digest. IP6
strongly inhibited BACE1 activity in vitro (Figs. 4 and 5). In SH-SY5Y
cells, IP6 (SS) signiﬁcantly inhibited Ab production in a dose-
dependent manner, as described above. This observation was con-
sistent with the results that have been reported by Anekonda et al.,
in which the treatment of Tg2576 AD model mice with IP6 (SS)
slightly reduces the amounts of soluble Ab1–40 and insoluble Ab1–
42 in the frontal cortex of the brain [16]. This consistency of ﬁnd-
ings suggests that one mechanism of Ab reduction in these mice
is through BACE1 inhibition by IP6 (SS), although this was not con-
cluded by Anekonda et al. Although IP6 may chelate metals and re-
duce their absorption by the body [17,18], Anekonda et al. have
reported that the IP6 (SS) treatment of mice that were fed a nutri-
tionally balanced diet does not affect the status of brain metal ions
(Cu, Fe, and Zn) [16]. In our study, IP6 (SS) was not toxic to SH-
SY5Y cells, as described above. These observations suggested that
IP6 is safe to the body.
Although we detected IP4 in the unpolished rice extract and di-
gest, it did not inhibit BACE1 activity (Figs. 3 and 4). Likewise, IP5
did not signiﬁcantly inhibit BACE1 activity (Fig. 4). These results
indicated that myo-inositol needs to bear six phosphates to exert
its BACE1 inhibitory activity.
Several BACE1 substrates other than APP are known, and these
include neuregulin 1/heregulin-beta-2, b-galactoside a2,6-sialyl-
transferase, P-selectin glycoprotein ligand-1, IL-1 receptor-2, and
the voltage-gated sodium channel beta 2 subunit [19]. IP6 did
not inhibit the cleavage of neuregulin 1/heregulin-beta-2 (between
aa237 and aa238) by BACE1 (Supplementary Fig. 2), suggesting
that IP6 did not block the catalytic domain of BACE1. In addition,
IP6 does not bind to a peptide coding the BACE1 cleavage site of
APP, as determined by surface plasmon resonance analyses using
a BiacoreX system (our unpublished observations). These results
suggest that IP6 speciﬁcally inhibits APP digestion by modulating
BACE1 activity. This characteristic of IP6 is preferable for develop-
ing drugs/foods to prevent AD because adverse effects that possibly
result from the inhibition of the cleavage of BACE1 substrates other
than APP will likely be avoided. Also, because the APP expression
level in the SH-SY5Y cells did not increase by IP6 treatment despite
the decrease of b-CTF (Fig. 6B), IP6 not only inhibits BACE1 but per-
haps also activates a-secretases which cleave APP between b- and
c-site (within the Ab-domain). Taken together, rice components,
including IP6, are promising starting materials for the development
of potent and safe drugs and/or food to prevent AD.Acknowledgments
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